Design, Synthesis and Biological Evaluation of Tricyclic Diterpene Derivatives As Novel Neuroprotective Agents Against Ischemic Brain Injury.

Ying-Ying Wang,Yuan-Xue Gao,Wei Gao,Yuan Xu,Ya-Zhou Xu,Yun-Jie Wang,Sai Chang,Li-Gang Yu,Lu-Yong Zhang,Hong Liao,Lian-Fang Yang,Tao Pang,Wen-Wei Qiu
DOI: https://doi.org/10.1016/j.ejmech.2015.08.057
IF: 7.088
2015-01-01
European Journal of Medicinal Chemistry
Abstract:Lead compound 7 has neuroprotective effects, and it was discovered by screening a small synthetic natural product-like (NPL) library. Based on the lead, a series of tricyclic diterpene derivatives was designed and synthesized, and their neuroprotective effects were further evaluated against glutamate-, oxygen and glucose deprivation (OGD)- and nutrient deprivation-induced neuronal injury using cell-based assays. To our delight, most of these synthetic compounds exhibited increased neuroprotective effects and blood brain barrier (BBB) permeability without cellular toxicity. The most potent compound, compound 30, showed significantly improved neuroprotection against neuronal injury in primary neurons. Furthermore, compound 30 exhibited remarkable neuroprotection in transient middle cerebral artery occlusion (tMCAO) rats by reducing their infarct sizes and neurological deficit scores. A mechanistic exploration using in vitro and in vivo experiments showed that the neuroprotection of these compounds was at least partly mediated by improving the levels of glutathione (GSH), superoxide dismutase (SOD) and heme oxygenase-1 (HO-1) protein. Therefore, these tricyclic diterpene derivatives could be used as promising leads for the development of a new type of neuroprotective agents against ischemic brain injury. (C) 2015 Published by Elsevier Masson SAS.
What problem does this paper attempt to address?